• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DUSP2 通过招募 CSNK2A1 抑制胰腺癌细胞在低氧微环境中 AKT1 介导的抗凋亡作用。

DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer.

机构信息

Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

出版信息

Cancer Lett. 2023 Aug 1;568:216288. doi: 10.1016/j.canlet.2023.216288. Epub 2023 Jun 29.

DOI:10.1016/j.canlet.2023.216288
PMID:37390887
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxic tumor microenvironment (TME), which aids tumor progression, drug resistance, and immune evasion. Dual-specificity phosphatase 2 (DUSP2), a member of the mitogen-activated protein kinase phosphatase family, regulates pancreatic cancer metastasis. However, its role in the hypoxic TME in PDAC remains unknown. We explored the role of DUSP2 by simulating the hypoxic TME. DUSP2 significantly promoted apoptosis in PDAC both in vitro and in vivo, mainly through AKT1 rather than ERK1/2. Mechanistically, DUSP2 competed with AKT1 to bind to casein kinase 2 alpha 1 (CSNK2A1) and inhibited the phosphorylation of AKT1, which plays a crucial role in apoptosis resistance. Interestingly, aberrant activation of AKT1 resulted in an increase in the ubiquitin E3 ligase tripartite motif-containing 21 (TRIM21), which binds to and mediates the ubiquitination-dependent proteasomal degradation of DUSP2. Overall, we identified CSNK2A1 as a novel binding partner of DUSP2 that promotes PDAC apoptosis through CSN2KA1/AKT1 in an ERK1/2-independent manner. Activation of AKT1 also mediated proteasomal degradation of DUSP2 via the AKT1/TRIM21 positive feedback loop. We propose increasing the level of DUSP2 as a potential therapeutic strategy for PDAC.

摘要

胰腺导管腺癌(PDAC)的特征是缺氧肿瘤微环境(TME),这有助于肿瘤的进展、耐药性和免疫逃逸。双特异性磷酸酶 2(DUSP2)是丝裂原活化蛋白激酶磷酸酶家族的成员,调节胰腺癌的转移。然而,其在 PDAC 缺氧 TME 中的作用尚不清楚。我们通过模拟缺氧 TME 来探索 DUSP2 的作用。DUSP2 显著促进了 PDAC 在体外和体内的细胞凋亡,主要是通过 AKT1 而不是 ERK1/2。从机制上讲,DUSP2 与 AKT1 竞争结合酪蛋白激酶 2α1(CSNK2A1)并抑制 AKT1 的磷酸化,这在细胞凋亡抵抗中起着至关重要的作用。有趣的是,AKT1 的异常激活导致泛素 E3 连接酶三部分基序(TRIM)21 的增加,TRIM21 与 DUSP2 结合并介导其依赖泛素的蛋白酶体降解。总的来说,我们确定 CSNK2A1 是 DUSP2 的一种新型结合伙伴,通过 ERK1/2 独立的 CSN2KA1/AKT1 促进 PDAC 细胞凋亡。AKT1 的激活还通过 AKT1/TRIM21 正反馈环介导 DUSP2 的蛋白酶体降解。我们提出增加 DUSP2 的水平作为 PDAC 的一种潜在治疗策略。

相似文献

1
DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer.DUSP2 通过招募 CSNK2A1 抑制胰腺癌细胞在低氧微环境中 AKT1 介导的抗凋亡作用。
Cancer Lett. 2023 Aug 1;568:216288. doi: 10.1016/j.canlet.2023.216288. Epub 2023 Jun 29.
2
MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.miR-361-3p 通过降解 DUSP2 mRNA 调控 ERK1/2 诱导的 EMT 进程在胰腺导管腺癌中。
Cell Death Dis. 2018 Jul 24;9(8):807. doi: 10.1038/s41419-018-0839-8.
3
Suppression of Extracellular Vesicle VEGF-C-mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor.一种选择性 HDAC1/2 抑制剂抑制细胞外囊泡 VEGF-C 介导的淋巴管生成和胰腺癌早期转移。
Mol Cancer Ther. 2021 Sep;20(9):1550-1560. doi: 10.1158/1535-7163.MCT-20-0963. Epub 2021 Jul 1.
4
Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.缺氧/HIF1α通过调控双特异性磷酸酶2(DUSP2)诱导ERBB2阳性乳腺癌细胞对拉帕替尼产生耐药性。
Oncotarget. 2015 Feb 10;6(4):1967-80. doi: 10.18632/oncotarget.2806.
5
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.碳酸酐酶 9 通过调节 pH 值介导激活 KRAS 的胰腺癌细胞对低氧的存活反应。
Gastroenterology. 2019 Sep;157(3):823-837. doi: 10.1053/j.gastro.2019.05.004. Epub 2019 May 9.
6
Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells.缺氧抑制双特异性磷酸酶-2 增加人癌细胞的化疗耐药性和恶性程度。
J Clin Invest. 2011 May;121(5):1905-16. doi: 10.1172/JCI44362. Epub 2011 Apr 1.
7
Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.双特异性磷酸酶-2 的缺失通过上调结肠癌中的白细胞介素-8 促进血管生成和转移。
J Pathol. 2017 Apr;241(5):638-648. doi: 10.1002/path.4868.
8
Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.灵长类特异性 miRNA-637 通过抑制 Akt1 表达抑制人胰腺导管腺癌细胞的肿瘤发生。
Exp Cell Res. 2018 Feb 15;363(2):310-314. doi: 10.1016/j.yexcr.2018.01.026.
9
DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.DUSP2 通过 PTPN7 下调 MEK/ERK 和 P38 MAPK 信号通路影响膀胱癌预后。
Cell Signal. 2023 Dec;112:110893. doi: 10.1016/j.cellsig.2023.110893. Epub 2023 Sep 20.
10
ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer.ACLP 通过 ACLP-PPARγ-ACLP 反馈回路促进胰腺癌中癌症相关成纤维细胞的激活和肿瘤转移。
Cancer Lett. 2022 Sep 28;544:215802. doi: 10.1016/j.canlet.2022.215802. Epub 2022 Jun 19.

引用本文的文献

1
Ellagic Acid Mediates the Delay of Dermal Fibroblast Senescence via CSNK2A1.鞣花酸通过酪蛋白激酶2α1介导真皮成纤维细胞衰老的延迟。
Clin Cosmet Investig Dermatol. 2025 Aug 20;18:1971-1983. doi: 10.2147/CCID.S523963. eCollection 2025.
2
PLGA-microspheres carried circ_0003251 alleviate intervertebral disc degeneration via the miR-637/AKT1 axis.载有circ_0003251的聚乳酸-羟基乙酸共聚物微球通过miR-637/AKT1轴减轻椎间盘退变。
J Transl Med. 2025 Jul 25;23(1):840. doi: 10.1186/s12967-025-06800-z.
3
Selective targeting of the AKT1 (E17K) mutation: advances in precision oncology and therapeutic design.
AKT1(E17K)突变的选择性靶向:精准肿瘤学与治疗设计的进展
Discov Oncol. 2025 Jul 3;16(1):1257. doi: 10.1007/s12672-025-03083-0.
4
Exploring the potential mechanisms of Da ChaiHu decoction against pancreatic cancer based on network pharmacology prediction and molecular docking approach.基于网络药理学预测和分子对接方法探索大柴胡汤抗胰腺癌的潜在机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 23. doi: 10.1007/s00210-025-04107-w.
5
Macroautophagy/autophagy promotes resistance to KRAS-targeted therapy through glutathione synthesis.巨自噬/自噬通过谷胱甘肽合成促进 KRAS 靶向治疗的耐药性。
Cancer Lett. 2024 Nov 1;604:217258. doi: 10.1016/j.canlet.2024.217258. Epub 2024 Sep 12.
6
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing.通过单细胞 RNA 测序研究高表达 TP53 的骨肉瘤细胞在肿瘤微环境中的细胞通讯和信号通路。
Med Oncol. 2024 Mar 25;41(5):93. doi: 10.1007/s12032-024-02318-4.
7
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.转录因子 ATMIN 促进鼻咽癌的化疗耐药性。
Cell Death Dis. 2024 Feb 6;15(2):112. doi: 10.1038/s41419-024-06496-x.
8
Ubiquitin signaling in pancreatic ductal adenocarcinoma.胰腺导管腺癌中的泛素信号传导
Front Mol Biosci. 2023 Dec 20;10:1304639. doi: 10.3389/fmolb.2023.1304639. eCollection 2023.